Adtalem Global Education (NYSE:CVSA) CEO Stephen Beard Sells 4,667 Shares of Company Stock

Adtalem Global Education Inc. (NYSE:CVSA) CEO Stephen Beard sold 4,667 shares of Adtalem Global Education stock in a transaction dated Friday, October 9th. The shares were sold at an average price of $130.77, for a total transaction of $610,303.59. Following the completion of the sale, the chief executive officer owned 469,158 shares in the company, valued at approximately $61,351,791.66. This represents a 0.98% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Trading Down 0.8%

Adtalem Global Education stock opened at $129.27 on Friday. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.45. The firm has a 50-day moving average price of $128.45 and a two-hundred day moving average price of $123.73. The firm has a market capitalization of $4.38 billion, a price-to-earnings ratio of 18.36, a PEG ratio of 0.97 and a beta of 0.65. Adtalem Global Education Inc. has a 52-week low of $86.97 and a 52-week high of $156.26.

Adtalem Global Education (NYSE:CVSA) last announced its quarterly earnings results on Thursday, August 6th. The company reported $2.09 EPS for the quarter, beating the consensus estimate of $1.90 by $0.19. The company had revenue of $501.38 million for the quarter. Adtalem Global Education had a net margin of 12.87% and a return on equity of 20.88%. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. Sell-side analysts expect that Adtalem Global Education Inc. will post 9.00 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on CVSA. Truist Financial downgraded Adtalem Global Education from a “buy” rating to a “hold” rating and set a $140.00 target price on the stock. in a research note on Thursday, September 3rd. Weiss Ratings cut Adtalem Global Education from a “hold (c+)” rating to a “hold (c)” rating in a research note on Tuesday. Wall Street Zen raised Adtalem Global Education from a “hold” rating to a “buy” rating in a report on Sunday, September 27th. Finally, BMO Capital Markets cut their price objective on shares of Adtalem Global Education from $148.00 to $145.00 and set an “outperform” rating on the stock in a research note on Monday, October 5th. Two equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, Adtalem Global Education presently has an average rating of “Hold” and an average target price of $151.67.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Adtalem Global Education stock. Kendall Capital Management bought a new position in shares of Adtalem Global Education Inc. (NYSE:CVSA) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 11,622 shares of the company’s stock, valued at approximately $1,449,000. 98.84% of the stock is currently owned by institutional investors.

About Adtalem Global Education

Adtalem Global Education is an education services company that provides professional, postsecondary and healthcare-focused education through institutions and brands serving students and working professionals. Its offerings include degree programs, career training, certification preparation and continuing education.

The company’s academic institutions include Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, Ross University School of Veterinary Medicine and the Medical University of the Americas.